Abstract |
Oxoplatinum (USSR) caused a more pronounced anticancer effect than platidiam (CSSR) when treating nude mice with the transplantable human melanoma. Moderate lymphopenia was found with therapeutic doses of oxoplatinum and platidiam, but there was no direct inhibition of the energy metabolism of lymphocytes in the peripheral blood. In the cancer cells and in the lymphocytes infiltrating the tumour oxoplatinum caused a significant decrease in the alpha-GPDG activity realizing the binding of the glycolysis and oxidation which might evidence for a definite selective action of oxoplatinum on the human melanoma.
|
Authors | I K Bukharova, L I Osokina, E S Revazova |
Journal | Eksperimental'naia onkologiia
(Eksp Onkol)
Vol. 10
Issue 5
Pg. 55-7
( 1988)
ISSN: 0204-3564 [Print] Ukraine |
Vernacular Title | DeÄstvie oksoplatiny i platidiama na shtammy melanomy cheloveka i funktsional'nuiu aktivnost' limfotsitov krovi u bectimusnykh mysheÄ. |
PMID | 3208691
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Cisplatin
- diamminedichlorodihydroxyplatinum IV
|
Topics |
- Animals
- Cisplatin
(analogs & derivatives, pharmacology, therapeutic use)
- Leukocyte Count
- Lymphocytes
(drug effects, enzymology)
- Melanoma, Experimental
(blood, drug therapy)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Tumor Cells, Cultured
|